These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 35038835

  • 1. Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency.
    Yoon JY, Cheon CK, Lee JH, Kwak MJ, Kim HJ, Kim YJ, Lee JE, Chung WY, Kim J, Yoo JH.
    Ann Pediatr Endocrinol Metab; 2022 Mar; 27(1):37-43. PubMed ID: 35038835
    [Abstract] [Full Text] [Related]

  • 2. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A, Rogol AD, Elsiddig S, Khalil A, Alaaraj N, Alyafie F, Ahmed H, Elawwa A.
    J Pediatr Endocrinol Metab; 2021 Oct 26; 34(10):1263-1271. PubMed ID: 34291621
    [Abstract] [Full Text] [Related]

  • 3. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH, Kim YM, Lee GM, Yu J, Han HS, Yu J.
    J Korean Med Sci; 2022 Mar 21; 37(11):e90. PubMed ID: 35315601
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 2009 Feb 21; 94(2):483-90. PubMed ID: 19001519
    [Abstract] [Full Text] [Related]

  • 5. Criteria for First-Year Growth Response to Growth Hormone Treatment in Prepubertal Children With Growth Hormone Deficiency: Do They Predict Poor Adult Height Outcome?
    Straetemans S, De Schepper J, Thomas M, Tenoutasse S, Beauloye V, Rooman R.
    Front Endocrinol (Lausanne); 2019 Feb 21; 10():792. PubMed ID: 31849835
    [Abstract] [Full Text] [Related]

  • 6. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT, Elawwa A, Itani M, Jour C, De Sanctis V.
    Acta Biomed; 2019 Sep 23; 90(8-S):43-51. PubMed ID: 31544806
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr 23; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 10. Comparison of growth hormone treatment in patients with idiopathic short stature and idiopathic growth hormone deficiency.
    Kim SA, Choe YR, Yang EM, Kim CJ.
    Chonnam Med J; 2014 Aug 23; 50(2):63-6. PubMed ID: 25229018
    [Abstract] [Full Text] [Related]

  • 11. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group.
    J Clin Endocrinol Metab; 2010 May 23; 95(5):2089-98. PubMed ID: 20207829
    [Abstract] [Full Text] [Related]

  • 12. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD, Blethen SL, Sy JP, Veldhuis JD.
    Clin Endocrinol (Oxf); 2003 Feb 23; 58(2):229-37. PubMed ID: 12580940
    [Abstract] [Full Text] [Related]

  • 13. Is a Two-Year Growth Response to Growth Hormone Treatment a Better Predictor of Poor Adult Height Outcome Than a First-Year Growth Response in Prepubertal Children With Growth Hormone Deficiency?
    Straetemans S, Rooman R, De Schepper J.
    Front Endocrinol (Lausanne); 2021 Feb 23; 12():678094. PubMed ID: 34140931
    [Abstract] [Full Text] [Related]

  • 14. A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency.
    Gou P, Cheng X, Leng J, Su N.
    Ther Clin Risk Manag; 2022 Feb 23; 18():113-124. PubMed ID: 35342293
    [Abstract] [Full Text] [Related]

  • 15. Effect of Growth Hormone on Final Height in Children with Idiopathic Short Stature: A UAE, Eastern Region Experience.
    Mreish S, Kaplan W, Chedid F.
    Oman Med J; 2017 Nov 23; 32(6):467-470. PubMed ID: 29218122
    [Abstract] [Full Text] [Related]

  • 16. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ, Rikken B.
    Clin Endocrinol (Oxf); 1995 Apr 23; 42(4):365-72. PubMed ID: 7750190
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the growth response of children with growth hormone deficiency according to the peak growth hormone levels in provocation tests.
    Donbaloğlu Z, Singin B, Acar S, Bedel A, Barsal Çetiner E, Aydın Behram B, Parlak M, Tuhan H.
    Arch Pediatr; 2023 Nov 23; 30(8):573-579. PubMed ID: 37802668
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z, Li YH, Ma HM, Chen HS, DU ML, Gu YF.
    Zhonghua Er Ke Za Zhi; 2008 Oct 23; 46(10):757-62. PubMed ID: 19099881
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.